PathPlus(tm) MLANA / Melan-A Antibody (C-Terminus)

LifeSpan BioSciences

PathPlus(tm) MLANA / Melan-A Antibody (C-Terminus)

23

Immunohistochemistry: LS-B2665 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B2665 was determined to be 10 ug/ml.. IHC, IHC-P (10 µg/ml) Immunohistochemistry: LS-B2665 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B2665 was determined to be 10 ug/ml.

ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

0.7 mg/ml

Unconjugated

MLANA

melan-A

MART-1, MART1, melanoma antigen recognized by T-cells 1, antigen LB39-AA, antigen SK29-AA, epididymis secretory sperm binding protein, protein Melan-A

Rabbit

Human

2°C to 8°C

41116161